• Subscribe to Huron Insights
  • Submit RFP
  • Investor Relations
  • Careers
  • Contact Us

  • Industry
    • Aerospace
    • Automotive
    • Energy & Utilities
    • Financial Services
    • Government
    • Healthcare
    • Higher Education
    • Hospitality & Gaming
    • Life Sciences
    • Logistics
    • Manufacturing
    • Metals & Mining
    • Retail & Consumer Products
    • Technology, Media & Telecommunications
  • Expertise
    • Business Advisory
    • Enterprise Solutions & Analytics
    • Technology
  • Resources
  • Company
    • About Us
    • Contact Us
    • Locations
    • Our Experts
    • Leadership
    • Press Releases
    • Diversity & Community Affairs
    • Careers
HigherEd_ThoughtLeadership_Resize

Clinical Research Management Briefing - May 29, 2018

Contact Us Contact Us

Top Stories

Congress Approves Bill Giving Patients a ‘Right to Try’ Experimental Drugs

Under the legislation, patients with terminal conditions will be able to bypass the Food and Drug Administration (FDA) to access experimental drug treatments.

The New York Times, May 22

New Cancer Treatments Lie Hidden Under Mountains of Paperwork

Gathering and deciphering medical records are some of the biggest barriers in one organization’s quest to create a database that links cancer treatment outcomes with medical information.

The New York Times, May 21

 

Regulatory

FDA Plans to Speed Path to Approval for Some Gene Therapies, Starting With Hemophilia

The hope that gene therapy will change how illnesses get treated will be tested as the FDA announces a new policy.

STAT, May 22

 

Financial and Operations

After Controversy Over Industry Funding, NIH Halts Enrollment in Moderate Drinking Study

With its reputation on the line, the National Institutes of Health (NIH) stopped enrollment until a thorough review of the study and its funding is completed.

STAT, May 17

 

Technology

Former FDA Commissioner Califf to Pharma: Opening Up on Health Data Requires Overcoming Risk

Patients are on board with their health data being collected – it’s the doctors and medical industry that need convincing.

MM&M, May 16

 

Pharm and Biotech

Why the Pharmaceutical Industry is Giving Up the Search for an Alzheimer’s Cure

The complexity of Alzheimer’s is causing major setbacks to pharmaceutical companies who are conducting research – all at a time when the number of older adults in the United States grows.

Quartz, May 20

 

Spotlight

Cloud Adoption Trends in Research Administration

Higher education and independent research institutions are benefiting by migrating their administrative software to cloud-based systems.

Huron

CSU Reduces Faculty Research Administrative Burden

In less than a year, Colorado State University (CSU) reduced its number of certifications per quarter by more than 1,000 with Huron’s Employee Compensation Compliance solution.

Huron

Contact Us

Related Articles

  • Clinical Research Management Briefing - May 21, 2018
  • Clinical Research Management Briefing - May 14, 2018
  • Clinical Research Management Briefing - May 7, 2018
Share:
Contact Us Contact Us

Subscribe to Huron Insights

Sign Up Today!

Clinical Research Management Briefing - May 29, 2018

  • Rick Rohrbach

    Rick Rohrbach

    Managing Director

    Industry:

    Higher Education | Healthcare | Technology Media and Telecommunications | Life Sciences | Retail

    Contact Me LinkedIn Read My Bio
  • Leah Guidry

    Leah Guidry

    Managing Director

    Industry:

    Higher Education | Healthcare | Life Sciences

    Contact Me LinkedIn Read My Bio
+
  • Facebook Icon
  • Google Plus Icon
  • Linkedin Icon
  • Twitter Icon

© 2019 Huron Consulting Group Inc. and affiliates. All rights reserved. Huron is a global consultancy and not a CPA firm, and does not provide attest services, audits, or other engagements in accordance with standards established by the AICPA or auditing standards promulgated by the Public Company Accounting Oversight Board ("PCAOB"). Huron is the trading name of Pope Woodhead & Associates Ltd.

We use cookies on our website to provide you with a more personalized digital experience, enable website functionality and understand the performance of our site. You may review our Privacy Statement and our Cookies Policy. By using this site you agree to our use of cookies. I Accept

  • Privacy Statement
  • Terms & Conditions
  • Cookies Policy
  • Fraudulent Offers